Advanced search
Publication Cover
Infectious Diseases Volume 52, 2020 - Issue 4
Submit an article Journal homepage
181
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

No progression of subclinical atherosclerosis in HIV-infected patients starting an initial regimen including tenofovir alafenamide/emtricitabine plus raltegravir, dolutegravir or elvitegravir/cobicistat during a two-year follow-up

Leonardo CalzaDepartment of Medical and Surgical Sciences, Section of Infectious Diseases, “Alma Mater Studiorum”, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, ItalyCorrespondence[email protected]
,
Marco BorderiDepartment of Medical and Surgical Sciences, Section of Infectious Diseases, “Alma Mater Studiorum”, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
,
Vincenzo ColangeliDepartment of Medical and Surgical Sciences, Section of Infectious Diseases, “Alma Mater Studiorum”, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
,
Aurora BorioniDepartment of Medical and Surgical Sciences, Section of Infectious Diseases, “Alma Mater Studiorum”, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
,
Simona ColadonatoDepartment of Medical and Surgical Sciences, Section of Infectious Diseases, “Alma Mater Studiorum”, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
,
Bianca GranozziDepartment of Medical and Surgical Sciences, Section of Infectious Diseases, “Alma Mater Studiorum”, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
&
Pierluigi VialeDepartment of Medical and Surgical Sciences, Section of Infectious Diseases, “Alma Mater Studiorum”, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
 show all
Pages 249-256 | Received 22 Nov 2019, Accepted 16 Dec 2019, Published online: 26 Dec 2019

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (1)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.